Hybridoma cell line 7D7 secreting CAV-2 monoclonal antibody, monoclonal antibody secreted by hybridoma cell line 7D7, and applications of monoclonal antibody
A hybridoma cell line, CAV-2 technology, applied in the field of monoclonal antibodies, can solve the problem of weak virulence of canine adenovirus type 2
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0037] The technical solution of the present invention will be further described below in conjunction with the accompanying drawings, but it is not limited thereto. Any modification or equivalent replacement of the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention should be covered by the present invention. within the scope of protection.
[0038] The invention provides a method for preparing anti-CAV-2 monoclonal antibodies that recognize different epitopes, the specific contents are as follows:
[0039] 1 Materials and methods
[0040] 1.1 Materials, experimental animals and reagents
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com